Indeed, our cell, animal, and patient results consistently showed that high acetate uptake/ACSS2 expression can occur in glucose- or nutrient-replete conditions in lower-grade liver cancer cells or in tumors that feature reduced hypoxia. Here, ACSS2 is linked to liver cancer.